Animal-based hyaluronic acid fillers: Scientific and technical considerations

Plastic and Reconstructive Surgery

Volumn 120, Issue 6 S SUPPL., 2007, Pages

  Clark III, Clifford P ^a,b  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FILLER; HYALURONIC ACID;

CLINICAL PRACTICE; COMPARATIVE STUDY; FLOW KINETICS; FOOD AND DRUG ADMINISTRATION; HUMAN; HYPERSENSITIVITY REACTION; PRIORITY JOURNAL; REVIEW; STATISTICAL SIGNIFICANCE;

ANIMALS; DERMATOLOGIC AGENTS; HUMANS; HYALURONIC ACID; INJECTIONS, INTRADERMAL; REJUVENATION; SKIN AGING;

EID: 37349026609     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.prs.0000248806.70402.7b     Document Type: Review

References (26)

1. Meyer, K., and Palmer, J. W. The polysaccharide of the vitreous humour. J. Biol. Chem. 107: 629, 1934.
2. Toole, B. P. Hyaluronan: From extracellular glue to pericellular cue. Nat. Rev. Cancer 4: 528, 2004.
3. Balazs, E. A., and Sweeney, D. B. The use of hyaluronic acid and collagen preparations in eye surgery. In C. L. Schepes and C. D. J. Regan (Eds.), Controversial Aspects of the Management of Retinal Detachment. Vol. 3. Boston: Little, Brown, 1965. Pp. 200-202.
4. Balazs, E. A., Freeman, M. I., Kloti, R., Meyer-Schwickerath, G., Reynault, F., and Sweeney, D. B. Hyaluronic acid and the replacement of vitreous and aqueous humor. In E. B. Streiff (Ed.), Modern Problems in Ophthalmology Vol. 10. (Secondary Detachment of the Retina, Hausanne, 1970). Basel: S. Karger, 1972. Pp. 3-21.
5. Laurent, T. C., Hellsing, K., and Gelotte, B. Cross-linked gels of hyaluronic acid. Acta Chem. Scand. 18: 274, 1964.
6. Balazs, E. A., Heshchuer, E. A., and Heshchuer, A. B and P: Chemically modified hyaluronic acid preparation and method of recovery thereof from animal tissues. U.S. Patent 4,713,448. Ridgefield, N.J.: Biomatrix, Inc., 1985. Pp. 1-18.
7. Balazs, E. A., and Denlinger, J. L. Viscosupplementation: A new concept in the treatment of osteoarthritis. J. Rheumatol. 20(Suppl. 39): 3, 1993.
8. Andre, P. Hyaluronic acid and its use as a "rejuvenation" agent in cosmetic dermatology. Semin. Cutan. Med. Surg. 23: 218, 2004.
9. Shiedlin, T., Bigelow, R., Christopher, W., et al. Evaluation of hyaluronan from different sources: Streptococcus zooepidernicus, rooster comb, bovine vitreous, and human umbilical cord. Biomacromolecules 5: 2122, 2004.
10. Miller, B. J. Hylaform (Hylan B Gel) background and non-clinical studies. Presented at the Technology Summit Meeting, New York, N.Y., June 4, 2005.
11. Manna, F., Dentuni, M., Desirderi, P., et al. Comparative chemical evaluations of two commercially available derivatives of hyaluronic acid (Hylaform from rooster combs and Restylane from Streptococcus) used for soft tissue augmentation. J. Eur. Acad. Dermatol. Venerol. 13: 183, 1999.
12. Micheels, P. Human anti-hyaluronic acid antibodies: Is it possible? Dermatol. Surg. 27: 185, 2001.
13. Goldberg, V. M., and Coutts, R. D. Pseudoseptic reactions to hylan viscosupplementation: Diagnosis and treatment. Clin. Orthop. 419: 130, 2004.
14. Bucher, W., Otto, T., and Hamburger, M. I. Differentiation of hyaluroniate products by qualitative differences in their immunogenerative in rabbits: Possible mechanism for product specific advance reactions? Arthritis Rheum. 46: 2543, 2002.
15. Wik, H. B., and Wik, O. Rheology of hyaluronan and its derivatives. Proceedings of the Wenner-Bren Foundations. International symposium held in honor of Andre A. Balazs, Stockholm, Sweden, September 28-21, 1996. London: Portland Press, 1998. Pp. 25-32.
16. Phillips, G. O. Degradation of hyaluronan systems by free radicals. In T. C. Laurent (Ed.), The Chemistry, Biology, and Medical Applications of Hyaluronan and its Derivatives. London: Portland Press, 1998. Pp. 93-112.
17. Lepperdinger, G., Fehrer, C., and Reitinger, S. Biodegradation of hyaluronan. In H. G. Gary and C. A. Hale (Eds.), Chemistry and Biology of Hyaluronan. New York: Elsevier, 2004. Pp. 71-82.
18. Miller, B. J. Personal communication. August 2005.
19. Carruthers, J., Carruthers, A., and Maberley, D. Deep resting glabellar rhytides respond to BTX-A and Hylan B. Dermatol. Surg. 5: 539, 2003.
20. Freitas, J. P., Filipe, P., Emerit, I., et al. Hyaluronic acid in progressive systemic sclerosis. Dermatology 192: 46, 1996.
21. Soltes, L., Lath, D., and Mendichi, R. Radical degradation of high molecular weight hyaluronan: Inhibition of the reaction by ibuprofen enantromers. Exp. Clin. Pharmacol. 23: 65, 2001.
22. Piacquadio, D., Jarcho, M., and Goltz, R. Evaluation of Hylan B gel as a soft-tissue augmentation implant material. J. Am. Acad. Dermatol. 36: 544, 1997.
23. Larsen, N. E., Heshchiner, E., Pollah, C. T., et al. Evaluation of hylan B (hylan gel) as soft tissue dermal implants. In A. G. Mikos, K. W. Heong, M. L. Radomsky, J. A. Tomada, and M. J. Yaszemski (Eds.), Polymers in Medicine and Pharmacy (Proceedings of Materials Research Society, Spring Meeting, April 17-21, 1995, San Francisco, Calif.). Pittsburgh, Pa.: Materials Research Society, 1995. Pp. 193-197.
24. Piacquadio, D. J., Larsen, N. E., Denlinger, J. L., et al. Hylan B Gel (Hylaform) as a soft tissue augmentation material In A. W. Klein (Ed.), Tissue Augmentation in Clinical Practice. New York: Marcel Dekker, 1998.
25. Gendler, E., and Ruskin, S. Practice survey results. Presented at the Technology Summit Meeting, New York, N.Y., June 4, 2005.
26. Lowe, N., Maxwell, C. A., Lowe, P., et al. Hyaluronic acid skin fillers: Adverse reactions and skin testing. J. Am. Acad. Dermatol. 4: 930, 2001.